Get Support – Call 1-888-MITO-411

Clinical Trials and COVID-19

Print Friendly, PDF & Email

Meet Dr. Matthew Klein from PTC Therapeutics and learn how to best navigate clinical trials during COVID-19.

About the Speaker

Matthew Klein, MD, MS, FACS

Matthew Klein, MD, MS, FACS

Dr. Matthew B. Klein, MD, MS, FACS is Chief Development Officer at PTC Therapeutics, Inc. Prior to joining PTC, Dr. Klein was CEO and Chief Medical Officer of BioElectron Technology Corporation, a biotechnology company focused on development of redox active small molecules for mitochondrial disease and related disorders of oxidative stress. Prior to joining BioElectron, Dr. Klein was the Auth-Washington Research Foundation Chair of Restorative Burn Surgery at the University of Washington. Dr. Klein completed his undergraduate degree at the University of Pennsylvania where he graduated summa cum laude and Phi Beta Kappa, and received his MD degree with honors from Yale University.

Upcoming Events

View All
View Calendar

Expert Series

View All
View Calendar

Last Presentation

Expert Series: How to Keep Airways Clear and Breathing Great – Bulbar Function and Respiratory Muscles
Presented April 11, 2025

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org